Gujarat Terce Laboratories Ltd

BSE: GUJTERC524314ISIN INE499G01013

Healthcare
Pharmaceuticals

Share price

₹44.15-1.06 (-2.34%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹50.00
52W low: ₹29.00
Off 52W high: -11.70%
1M return: +26.76%
3M return: +5.24%
6M return: +20.50%
1Y return: -3.73%
20D avg volume: 7,692
50 DMA: ₹38.72
200 DMA: ₹37.80

Key ratios Standalone

Market cap: ₹34.40 Cr
Current price: ₹44.15
52W high / low: ₹50.00 / ₹29.00
Face value: ₹10.00
P/E: 16.47
P/B: 3.88
EPS (TTM): ₹2.68
Book value / share: ₹11.38
ROE: 23.56%
ROCE: 23.60%
Operating margin: -0.12%
Net margin: -1.98%
Debt / equity: 0.13
Net debt: ₹-1.56 Cr
Interest cover: 17.83
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 54.0 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	9.00	11.40	12.29	12.93	10.85	12.32	12.68	13.30	11.89	—
	0.48	0.08	0.13	0.06	0.10	0.09	0.07	0.08	0.07	—
	9.48	11.48	12.42	12.98	10.95	12.41	12.75	13.38	11.96	—
	9.63	10.82	11.29	11.20	11.02	11.44	11.77	11.87	12.03	—
	0.14	0.71	2.08	1.30	1.98	3.06	1.88	1.20	3.00	—
	2.56	3.31	2.83	2.75	2.59	2.67	2.84	1.65	2.98	—
	3.73	4.12	4.03	4.17	3.75	4.17	3.98	4.21	3.84	—
	0.03	0.03	0.04	0.07	0.05	0.07	0.08	0.13	0.13	—
	0.11	0.13	0.10	0.10	0.10	0.10	0.10	0.09	0.09	—
	2.54	2.65	2.62	2.55	2.70	1.60	3.13	3.22	3.27	—
	-0.15	0.66	1.13	1.78	-0.07	0.97	0.98	1.51	-0.07	—
	0.00	-0.45	0.00	0.00	0.00	0.00	—	—	—	—
	-0.15	0.20	1.13	1.78	-0.07	0.97	0.98	1.51	-0.07	—
	0.03	0.10	0.37	0.38	-0.03	4.36	0.03	0.03	0.01	—
	-0.18	0.10	0.76	1.40	-0.04	-3.39	1.01	1.48	-0.08	—
	-0.23	0.13	0.95	1.89	-0.12	-9.14	1.36	2.00	-0.10	—
Key metrics
	-0.01	0.36	1.27	1.95	0.08	1.14	1.16	1.73	0.15	—
	-0.10%	3.20%	10.30%	15.10%	0.70%	9.30%	9.10%	13.00%	1.30%	—
	-2.00%	0.90%	6.20%	10.80%	-0.40%	-27.50%	8.00%	11.10%	-0.70%	—
	—	1.70%	—	16.90%	—	10.20%	—	—	—	—
	-17.10%	-7.50%	-3.10%	-2.80%	-8.70%	—	—	—	—	—
	-350.00%	102.90%	-24.80%	-5.40%	50.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	45.62	47.47	50.20	—
	0.75	0.34	0.31	—
	46.36	47.81	50.50	—
	42.94	44.33	47.11	—
	4.23	6.07	9.14	—
	11.45	11.48	10.15	—
	16.05	16.07	16.19	—
	0.17	0.18	0.42	—
	0.44	0.42	0.38	—
	10.36	10.52	11.21	—
	3.42	3.49	3.39	—
	-0.45	-0.45	0.00	—
	2.96	3.03	3.39	—
	0.88	0.83	4.37	—
	2.08	2.20	-0.98	—
	2.74	2.92	-2.62	—
Key metrics
	3.57	3.63	4.19	—
	7.83%	7.60%	8.30%	—
	4.56%	4.60%	-2.00%	—
	—	23.60%	37.40%	—
	-7.18%	-5.40%	—	—
	—	324.50%	—	—
	—	1.68	2.71	—
	—	0.78	-3.12	—
	—	0.13	0.15	—
	—	-1.56	0.16	—
	—	54.0	37.5	—
Balance sheet
	—	24.55	22.83	—
	—	14.41	12.02	—
	—	2.86	0.78	—
	—	4.87	5.07	—
	—	3.73	3.68	—
	—	1.43	1.27	—
	—	3.25	3.65	—
	—	1.58	3.61	—
	—	10.95	12.64	—
	—	1.30	0.94	—
	—	1.27	0.64	—
	—	0.03	0.30	—
	—	9.73	6.48	—
Cash flow
	—	1.71	3.06	—
	—	-0.11	0.46	—
	—	0.47	-2.83	—
	—	0.03	-0.35	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -7.18%
Profit YoY (TTM): +321.28%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 40.03%

Quarter	September 2026	June 2026
Promoter %	40.03%	40.03%

Holder	Type	Holding	Previous	Change
AALAP NATUBHAI PRAJAPATI	Promoter	17.35%	17.35%	0.00%
ABUNDANT TRADE LINK PRIVATE LIMITED	Promoter	13.81%	13.81%	0.00%
NATWARBHAI PARSOTTAM PRAJAPATI	Promoter	8.16%	8.16%	0.00%
DHEERAJ KUMAR LOHIA	Public	2.03%	1.04%	+0.99%
SAGAR SAXENA	Public	1.35%	1.35%	0.00%
GANESH VETRIVEL PERIASAMY	Public	1.26%	1.25%	+0.01%
RISHABH NEGI	Public	1.01%	1.01%	0.00%
AMRITBHAI P. PRAJAPATI	Promoter	0.40%	0.40%	0.00%
SHOBHANABEN NATVARBHAI PRAJAPATI	Promoter	0.21%	0.21%	0.00%
SHACHI RAVI OZA	Promoter Group	0.10%	0.10%	0.00%
PRAJAPATI MANJULABEN S	Promoter	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Gujarat Terce Laboratories Ltd S	34	44.15	16.47	23.60%	-7.18% TTM	+321.28% TTM	-3.73%

Filings & corporate actions

Recent announcements

Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve The Unaudited Standalone ....29 Oct 2026 · Board Meeting / Board Meeting
Detailed disclosure is attached.9 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Detailed disclosure is attached.27 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Detailed disclosure is attached21 Aug 2026 · AGM/EGM / AGM
Detailed disclosure is attached.21 Aug 2026 · AGM/EGM / AGM
Detailed disclosure is attached.21 Aug 2026 · Company Update / Change in Directorate
Corrigendum/Revised intimation regarding Re-appointment of Managing Director & Chief Executive Officer of the Company- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) ....21 Aug 2026 · Company Update / Change in Directorate
Detailed disclosure is attached.8 Aug 2026 · Company Update / Newspaper Publication
Detailed disclosure is attached.7 Aug 2026 · Board Meeting / Outcome of Board Meeting
Detailed disclosure is attached.7 Aug 2026 · Result / Financial Results
Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited Standalone ....1 Aug 2026 · Board Meeting / Board Meeting
Detailed disclosure is attached.30 Jul 2026 · Company Update / Newspaper Publication
41st AGM of the shareholders of Gujarat Terce Laboratories Limited will be held on 21st August, 2026 at 12:00 noon through Video Conferencing or any other Audio-Visual Means facility28 Jul 2026 · AGM/EGM / AGM
Annual Report for FY: 2025-26 is attached.28 Jul 2026 · Others / Reg. 34 (1) Annual Report
Please find enclosed herewith the certificate received from Bigshare Services Private Limited, the registrar and share transfer agent, in respect of the dematerialisation request received ....14 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Detailed disclosure is enclosed.25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Detailed disclosure is attached.3 Jun 2026 · Company Update / Investor Presentation
The amended code is enclosed.1 Jun 2026 · Company Update / General
Detailed disclosure is attached30 May 2026 · AGM/EGM / AGM
Copy of the newspaper publication for the financial results for the year ended 31 March 2026.30 May 2026 · Company Update / Newspaper Publication
Detailed disclosure is attached29 May 2026 · AGM/EGM / AGM
Detailed disclosure is attached.29 May 2026 · Board Meeting / Outcome of Board Meeting
Detailed disclosure is attached.29 May 2026 · Company Update / Change in Directorate
Detailed disclosure is attached29 May 2026 · Result / Financial Results
Annual Secretarial Compliance Report for the Financial Year 2025-2629 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
The Board Meeting to be held on 27/05/2026 has been revised to 29/05/2026 The Board Meeting to be held on 27/05/2026 has been revised to 29/05/2026 due to unavoidable circumstances.26 May 2026 · Company Update / Board Meeting Rescheduled
Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the Annual Audited ....13 May 2026 · Board Meeting / Board Meeting
Please find enlcosed herewith the certificate received from Bigshares Services Private Limited, the Registrar and Share Transfer Agent, in respect of the dematerialisation request received ....6 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Detailed disclosure is attached.27 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Detailed disclosure attached24 Feb 2026 · Company Update / General
Detailed disclosure as attached.5 Feb 2026 · Company Update / Newspaper Publication
Investor Presentation for third quarter and nine months ended on 31 December 20254 Feb 2026 · Company Update / Investor Presentation
Detailed disclosure is attached4 Feb 2026 · Result / Financial Results
Outcome of the Board Meeting held on 4 February 2026 - Unaudited Standalone Financial Results of the Company for the third quarter and nine months ended 31 December 20254 Feb 2026 · Board Meeting / Outcome of Board Meeting
This is to inform that the name of the Company''s Statutory Auditor, M.A. Shah & Co. has been changed to Shah Doshi Patel & Associates LLP.4 Feb 2026 · Company Update / General
Please find enclosed herewith the certificate received from Bigshare Services Private Limited, in respect of dematerialisation request received by them for the Company during the period ....7 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 ,inter alia, to consider and approve Unaudited Financial ....28 Dec 2025 · Board Meeting / Board Meeting
Closure of Trading window: Unaudited Financial Results for the quarter ended on 31st March, 2025.28 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aalap Natubhai Prajapati17 Dec 2025 · Insider Trading / SAST / Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aalap Natubhai Prajapati17 Dec 2025 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

Board meetings

5 Nov 2026 Board Meeting - Financial Results
7 Aug 2026 Board Meeting - Financial Results